Adapting strategies for effective and efficient pediatric HIV case finding in low prevalence countries: risk screening tool for testing children presenting at high-risk entry points in Ethiopia

Autor: Wondimu Teferi, Steve Gutreuter, Alemayehu Bekele, Jelaludin Ahmed, Jemal Ayalew, Jessica Gross, Hanna Kumsa, Tenagnework Antefe, Semegnew Mengistu, Kelsey Mirkovic, Eric J. Dziuban, Christine Ross, Zena Belay, Tsegaye Tilahun, Desta Kassa, Susan Hrapcak

Publikováno v: BMC Infectious Diseases, Vol 22, Iss 1, Pp 1-9 (2022)

Abstract Background Implementing effective and efficient case-finding strategies is crucial to increasing pediatric antiretroviral therapy coverage. In Ethiopia, universal HIV testing is conducted for children presenting at high-risk entry points inc

Externí odkaz: https://doaj.org/article/7f3e653818604c1a8a74e855893c33dd

Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019–September 2020

Autor: Ariana M. Traub, Amy Medley, Jessica Gross, Margo Sloan, Anouk Amzel, Megan M. Gleason, Nimasha B. Fernando, Vincent Wong, Michael P. Grillo, Hilary T. Wolf, Teeb Al-Samarrai, Alean Frawley, Mosarwa Segwabe, Catherine Motswere, Evelyne Baramperanye, Valery Nzima, Magdalene Mange Mayer, Shirish Balachandra, Francois-Xavier N'siesi, Henri O. Longuma, Patricia Nyembo, Sikhathele Mazibuko, Tsegaye Tilahun, Wondimu Teferi, Olbeg Desinor, Jean-Louis Reginald, Teresa Simiyu, Lennah Nyabiage, Justine Mirembe, Mamorapeli Ts’oeu, Gerald Zomba, Mtemwa Nyangulu, Argentina Wate, Jessica Greenberg Cowan, Denis Mali, Ismelda Pietersen, Dolapo Ogundehin, Dennis Onotu, Akudo Ikpeazu, Esron Niyonsaba, Jackson Bamwesigye, Hlamalani Mabasa, Gurpreet Kindra, Sudhir Bunga, Fredrick Rwegerera, Edward Machage, Galal King'ori, Jacqueline Calnan, Esther Nazziwa, Godfrey Lingenda, Kebby Musokotwane, Ruth Bulaya-Tembo, Talent Maphosa, Meena Srivastava

Publikováno v: MMWR. Morbidity and Mortality Weekly Report. 71:894-898

During 2020, an estimated 150,000 persons aged 0-14 years acquired HIV globally (1). Case identification is the first step to ensure children living with HIV are linked to life-saving treatment, achieve viral suppression, and live long, healthy lives

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f977eae6a39dabee54d88ce445a9f515
https://doi.org/10.15585/mmwr.mm7128a2

Trends in Antiretroviral Therapy Eligibility and Coverage Among Children Aged15 Years with HIV Infection - 20 PEPFAR-Supported Sub-Saharan African Countries, 2012-2016

Autor: Amanda Burrage, Monita R. Patel, Wondimu Teferi, Laura N. Broyles, Kelsey R. Mirkovic, Eric J. Dziuban, Emilia D. Rivadeneira

Publikováno v: Morbidity and Mortality Weekly Report

Rapid disease progression and associated opportunistic infections contribute to high mortality rates among children aged15 years with human immunodeficiency virus (HIV) infection (1). Antiretroviral therapy (ART) has decreased childhood HIV-associate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd1e34ede530409856e01e2724c63300
https://pubmed.ncbi.nlm.nih.gov/29771871

Pediatric and adolescent HIV viral load coverage and suppression rates in the context of the COVID-19 pandemic in 12 PEPFAR-supported sub-Saharan African countries in 2019 and 2020.

Autor: Carpenter D; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Hast M; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Buono N; United States Agency for International Development, Washington, District of Columbia, United States of America., Hrapcak S; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Sato K; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Mrina R; Walter Reed Army Institute of Research, United States Military HIV Research Program, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America., Cox MH; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Agaba PA; Walter Reed Army Institute of Research, United States Military HIV Research Program, Silver Spring, Maryland, United States of America.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, Maryland, United States of America., Vrazo AC; United States Agency for International Development, Washington, District of Columbia, United States of America., Wolf H; US Department of State, Office of the United States Global AIDS Coordinator, Washington, District of Columbia, United States of America., Rivadeneira ED; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Shang JD; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Yaounde, Cameroon., Mayer MM; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Yaounde, Cameroon., Prao AH; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Abidjan, Côte d'Ivoire., Longuma HO; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of Congo., Kabwe C; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Kinshasa, Democratic Republic of Congo., Lwana PN; Ministry of Health, National AIDS Control Committee, Kinshasa, Democratic Republic of Congo., Tilahun T; United States Agency for International Development, Addis Ababa, Ethiopia., Ts'oeu M; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Maseru, Lesotho., Mutisya I; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya., Omoto LN; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya., Cowan JG; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Maputo, Mozambique., Deus MIJT; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Maputo, Mozambique., Fagbamigbe OJ; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Nigeria., Ene U; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Nigeria., Ikpeazu A; Federal Ministry of Health, Abuja, Nigeria., Ndlovu MB; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Pretoria, South Africa., Matiko E; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Schaad N; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Dar es Salaam, Tanzania., Bisimba J; United States Agency for International Development, Dar es Salaam, Tanzania., Lema E; United States Agency for International Development, Dar es Salaam, Tanzania., Musokotwane K; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Lusaka, Zambia., Maphosa T; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Harare, Zimbabwe., Buthelezi B; United States Agency for International Development, Pretoria, South Africa., Olarinoye A; HJF Medical Research International, Abuja, Nigeria., Lawal I; US Army Medical Research Directorate-Africa/ Walter Reed Army Institute of Research, Abuja, Nigeria., Mukungunugwa S; United States Agency for International Development, Harare, Zimbabwe., Mwambona JT; Walter Reed Army Institute of Research (WRAIR), Dar es Salaam, Tanzania., Wondimu T; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Addis Ababa, Ethiopia., Kathure IA; United States Agency for International Development, Nairobi, Kenya., Igboelina OD; United States Agency for International Development, Abuja, Nigeria., Nzima VN; United States Agency for International Development, Yaounde, Cameroon., Bissai RG; United States Agency for International Development, Yaounde, Cameroon., Lenka M; United States Agency for International Development, Maseru, Lesotho., Shasha W; United States Agency for International Development, Abidjan, Côte d'Ivoire., Olivier NK; United States Agency for International Development, Abidjan, Côte d'Ivoire., Matsinhe M; United States Agency for International Development, Maputo, Mozambique., Wate A; United States Agency for International Development, Maputo, Mozambique., Godfrey L; United States Agency for International Development, Lusaka, Zambia., Alexander H; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Alemnji G; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia., Lecher S; Division of Global HIV and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.

Publikováno v: PLOS global public health [PLOS Glob Public Health] 2024 Aug 01; Vol. 4 (8), pp. e0003513. Date of Electronic Publication: 2024 Aug 01 (Print Publication: 2024).